Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
Gargett, Tessa, Truong, Nga T H, Gardam, Bryan, Yu, Wenbo, Ebert, Lisa M, Johnson, Amy, Yeo, Erica C F, Wittwer, Nicole L, Tapia Rico, Gonzalo, Logan, Jesikah, Sivaloganathan, Purany, Collis, Maria, Ruszkiewicz, Andrew, Brown, Michael P
Published in Journal for immunotherapy of cancer (15.05.2024)
Published in Journal for immunotherapy of cancer (15.05.2024)
Get full text
Journal Article